Altarum and its subsidiary, KAI, provides a full range of clinical study assistance from protocol development through successful regulatory approval.
We offer complete CRO services for phase I–IV clinical trials and epidemiological studies in a wide variety of therapeutic areas in both adult and pediatric populations. Our database and Web designers develop innovative yet practical tools for the clinical research and scientific communities.
Our experience encompasses all phases of clinical research from design through analysis and final data submission in a wide variety of therapeutic areas including: alternative medicine, central nervous system (CNS), dermatology, endocrinology, infectious disease, pain, psychiatric disorders, rheumatology, and substance abuse.
In addition to these areas, we have specialized experience with vaccine, pediatric and geriatric studies.
Our full-service pharmacovigilance department that provides both post-marketing and clinical trial safety monitoring and reporting, utilizing the industry-recognized ARISg™ adverse event tracking system.
We offer expertise on signal detection/data mining and risk management to identify, assess, and strategically plan for mitigation of potential risks of marketed pharmaceutical products.